A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), M. Colombo(University of Milan), Aldo Manzin(Ospedale Maggiore), Maria Francesca Donato(University of Milan), G. Lunghi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alberto Morabito(University of Milan), Maria Grazia Rumi(University of Milan), E. Del Ninno(University of Milan), Massimo Clementi(Vita-Salute San Raffaele University)
Cited by 178
Related Papers
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the Limbs
|New England Journal of Medicine|1977|667
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661